FR335M - New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin. - Google Patents
New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin.Info
- Publication number
- FR335M FR335M FR836270A FR836270A FR335M FR 335 M FR335 M FR 335M FR 836270 A FR836270 A FR 836270A FR 836270 A FR836270 A FR 836270A FR 335 M FR335 M FR 335M
- Authority
- FR
- France
- Prior art keywords
- spasms
- treatment
- steroid drugs
- hydroxylated steroid
- coronary origin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR836270A FR335M (en) | 1960-06-16 | 1960-08-19 | New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR830184A FR1363865A (en) | 1960-06-16 | 1960-06-16 | New polyhydroxylated steroids and obtaining these compounds |
FR836270A FR335M (en) | 1960-06-16 | 1960-08-19 | New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin. |
Publications (1)
Publication Number | Publication Date |
---|---|
FR335M true FR335M (en) | 1961-03-27 |
Family
ID=8733554
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR830184A Expired FR1363865A (en) | 1960-06-16 | 1960-06-16 | New polyhydroxylated steroids and obtaining these compounds |
FR836270A Active FR335M (en) | 1960-06-16 | 1960-08-19 | New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin. |
FR836867A Active FR342M (en) | 1960-06-16 | 1960-08-26 | New tri-hydroxylated steroid drug, in particular for the treatment of spasms of coronary origin. |
FR836866A Active FR341M (en) | 1960-06-16 | 1960-08-26 | New tetrahydroxylated steroid drug, in particular for the treatment of spasms of coronary origin. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR830184A Expired FR1363865A (en) | 1960-06-16 | 1960-06-16 | New polyhydroxylated steroids and obtaining these compounds |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR836867A Active FR342M (en) | 1960-06-16 | 1960-08-26 | New tri-hydroxylated steroid drug, in particular for the treatment of spasms of coronary origin. |
FR836866A Active FR341M (en) | 1960-06-16 | 1960-08-26 | New tetrahydroxylated steroid drug, in particular for the treatment of spasms of coronary origin. |
Country Status (5)
Country | Link |
---|---|
CH (3) | CH411863A (en) |
ES (3) | ES268247A1 (en) |
FR (4) | FR1363865A (en) |
GB (2) | GB967078A (en) |
SE (2) | SE302454B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9649320B2 (en) | 2008-05-28 | 2017-05-16 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
-
1960
- 1960-06-16 FR FR830184A patent/FR1363865A/en not_active Expired
- 1960-08-19 FR FR836270A patent/FR335M/en active Active
- 1960-08-26 FR FR836867A patent/FR342M/en active Active
- 1960-08-26 FR FR836866A patent/FR341M/en active Active
-
1961
- 1961-06-09 SE SE6086/61A patent/SE302454B/xx unknown
- 1961-06-09 SE SE6085/61A patent/SE301966B/xx unknown
- 1961-06-15 ES ES0268247A patent/ES268247A1/en not_active Expired
- 1961-06-15 CH CH700061A patent/CH411863A/en unknown
- 1961-06-15 ES ES0268248A patent/ES268248A1/en not_active Expired
- 1961-06-15 CH CH699961A patent/CH413831A/en unknown
- 1961-06-15 ES ES0268249A patent/ES268249A1/en not_active Expired
- 1961-06-15 CH CH699861A patent/CH418331A/en unknown
- 1961-06-16 GB GB21873/61A patent/GB967078A/en not_active Expired
- 1961-06-16 GB GB48946/63A patent/GB967080A/en not_active Expired
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9649320B2 (en) | 2008-05-28 | 2017-05-16 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
US10206933B2 (en) | 2008-05-28 | 2019-02-19 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
US10857161B2 (en) | 2008-05-28 | 2020-12-08 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
US11833159B2 (en) | 2008-05-28 | 2023-12-05 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
US11471471B2 (en) | 2019-03-07 | 2022-10-18 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Also Published As
Publication number | Publication date |
---|---|
FR341M (en) | 1961-03-27 |
CH418331A (en) | 1966-08-15 |
ES268247A1 (en) | 1961-09-16 |
SE302454B (en) | 1968-07-22 |
FR342M (en) | 1961-03-27 |
SE301966B (en) | 1968-07-01 |
GB967078A (en) | 1964-08-19 |
CH413831A (en) | 1966-05-31 |
ES268248A1 (en) | 1961-09-16 |
GB967080A (en) | 1964-08-19 |
FR1363865A (en) | 1964-06-19 |
ES268249A1 (en) | 1961-09-16 |
CH411863A (en) | 1966-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR1593M (en) | Compositions for the treatment of acne. | |
FR335M (en) | New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin. | |
FR1009M (en) | Medicine for the treatment of angina pectoris. | |
BE612141Q (en) | New drugs in particular for the treatment of spasms of coronary origin. | |
FR334M (en) | New dinitrated steroid drug, in particular for the treatment of spasms of coronary origin. | |
FR2969M (en) | New drug in particular for the treatment of spasms of coronary or visceral origin. | |
FR2778M (en) | New drugs, in particular for the treatment of spasms of coronary, vascular or visceral origin. | |
FR1764M (en) | New drug in particular for the treatment of spasms of coronary or visceral origin. | |
FR133M (en) | New dihydroxy drug, in particular for the treatment of spasms of coronary origin. | |
FR2338M (en) | New remedies intended in particular for the treatment of headaches of vascular origin. | |
FR1141M (en) | New drug in particular for the treatment of spasms of coronary origin. | |
FR1635M (en) | New drug in particular for the treatment of spasms of coronary origin. | |
FR129M (en) | New acetoxylated drug for the treatment of spasms of coronary origin. | |
FR55M (en) | New drug, particularly for the treatment of coronary spasms | |
FR2810M (en) | New drug in particular for the treatment of spasms of coronary or visceral origin. | |
FR1946M (en) | New drug in particular for the treatment of spasms of coronary origin. | |
FR2681M (en) | New drug in particular for the treatment of spasms of coronary origin. | |
FR3419M (en) | New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses. | |
FR151M (en) | New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses. | |
FR1598M (en) | New drug in particular for the treatment of spasms of vascular, coronary or visceral origin. | |
FR1886M (en) | New drug in particular for the treatment of spasms of coronary or visceral origin. | |
FR56F (en) | New drug in particular for the treatment of spasms of coronary or vascular origin. | |
FR2053M (en) | New drug in particular for the treatment of spasms of coronary or vascular origin. | |
BE616479A (en) | Agents for the treatment of vascular spasms | |
BE598672A (en) | Therapeutic composition for the treatment of hepatic disorders. |